Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy-Reference-Cited by-同舟云学术

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy

Published:2018-02-27 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Sougawa Nagako,Miyagawa Shigeru,Fukushima Satsuki,Kawamura Ai,Yokoyama Junya,Ito Emiko,Harada Akima,Okimoto Kaori,Mochizuki-Oda Noriko,Saito Atsuhiro,Sawa Yoshiki

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-21923-8.pdf

Reference31 articles.

1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).

2. Higuchi, T. et al. Functional and electrical integration of induced pluripotent stem cell-derived cardiomyocytes in a myocardial infarction rat heart. Cell Transplant. 24, 2479–2489 (2015).

3. Kawamura, M. et al. Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation 2, 87–95 (2013).

4. Funakoshi, S. et al. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci. Rep. 6, 19111 (2016).

5. Masumoto, H. et al. Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci. Rep. 4, 6716 (2014).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Stem Cells in the Treatment of Cardiovascular Diseases;International Journal of Molecular Sciences;2024-03-31

2. Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch;Stem Cell Research & Therapy;2024-03-13

3. Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials;Mechanisms of Ageing and Development;2023-09

4. Suspension culture improves iPSC expansion and pluripotency phenotype;Stem Cell Research & Therapy;2023-06-06

5. Culturing human pluripotent stem cells for regenerative medicine;Expert Opinion on Biological Therapy;2023-06-03